Amulet Capital-backed OPEN Health, a multi-disciplinary health communication and market access group, completed its acquisition of Pharmerit International, a provider of health economics and outcomes research. Financial terms were not disclosed. "Over the past two decades, we have proudly grown Pharmerit into a global strategic leader dedicated to our mission of demonstrating and communicating the value of innovative healthcare interventions with the development of rigorous evidence. In joining OPEN Health, we are significantly expanding our client base and will be able to provide a wider range of integrated services to our clients, notably the medical affairs groups. We very much look forward to working with the OPEN Health management and Amulet teams to contribute to the long-term growth of OPEN Health,” Marc Botteman, Pharmerit International Partner.